Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00787085 · ClinicalTrials.gov registry record
The Significance of Funguria in Hospitalized Patients
A clinical trial of Urinary Tract Infections, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- 919
- Enrollment target
- 2
- Study locations
NCT00787085: Completed study of Urinary Tract Infections, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
NCT00787085 is a study of Urinary Tract Infections that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 919 participants, above the 431-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (113% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00787085, a study of Urinary Tract Infections, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- 919 participants
- Enrollment target
- 2
- Study locations
Study Summary
This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
Conditions Studied
Study Locations (2)
California
- Cedars-Sinai Medical Center - Los Angeles
- Harbor-UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 919 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-02 |
What the finished NCT00787085 record still lists
NCT00787085 is an observational study that tracks outcomes without assigning an intervention. The registered 919 participants enrollment target is mid-sized for trials with a published cap, above the 431-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (113% higher).
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00787085 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00787085 about?
NCT00787085 is a clinical study titled "The Significance of Funguria in Hospitalized Patients". This investigation is a epidemiologic case-control study of the risk factors associated with nosocomial funguria (fungi in the urine).
What is the current status of trial NCT00787085?
This trial is currently completed. The enrollment target is 919 participants. The study started on 2001-09. Estimated completion is 2006-02.
What conditions does trial NCT00787085 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
Who is sponsoring clinical trial NCT00787085?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00787085 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00787085's enrollment target sits among peer trials
919 5th of 34 higher than 30 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
RECRUITING
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- NCT07174336 · 920 participants · Phase 3
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia